MarketPeel
Insider Trading Intelligence
Pricing
…
MK

Michael Aaron Kelly

FOLD
DIRECTOR · AMICUS THERAPEUTICS, INC. · CIK 0001769668
FILING MIX · LIFETIME79%/21%
BUYS
50
SELLS
13
TOTAL VALUE
$1.09M
COMPANIES
5
ACTIVE SINCE
Jul 2020
HOLDINGS NOW
161,170
AVG SELL PX
$14.50
TRADE KIND
SHOWING 63 / 63
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Michael Aaron Kelly, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-0.27%+0.84%-1.10%-1.10%—
14d1+100.00%+4.53%+2.02%+2.52%+2.52%—
30d1+0.00%-4.53%+3.50%-8.04%-8.04%—
60d1+0.00%-16.13%+7.77%-23.91%-23.91%—
90d1+0.00%-14.00%+8.68%-22.68%-22.68%—
180d1+100.00%+54.80%+13.12%+41.68%+41.68%—
1y1+100.00%+23.60%+25.57%-1.97%-1.97%—
2y1(1 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FOLD · 0 shares · as of Apr 27, 2026
018,71837,43656,15474,872202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 50 buys / 13 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PRME
PRIME MEDICINE, INC.
PURCHASEGRANT
Stock grant
75,000——75,000Jun 5, 2026Jun 8, 2026 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
15,970——15,970Jun 1, 2026Jun 3, 2026 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
11,069——11,069Jun 1, 2026Jun 3, 2026 ↗View →
NEO
NEOGENOMICS INC
SALE
23,077——0Jun 1, 2026Jun 3, 2026 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
23,077——67,086Jun 1, 2026Jun 3, 2026 ↗View →
BOOM
DMC GLOBAL INC.
PURCHASEGRANT
Stock grant
16,937——65,590May 13, 2026May 14, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
72,468$14.50$1.05M0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
36,111——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
42,467——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
45,423——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
74,872——0Apr 27, 2026Apr 27, 2026 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
SALE
30,474——0Apr 27, 2026Apr 27, 2026 ↗View →
PRME
PRIME MEDICINE, INC.
SALE
39,062——0Aug 1, 2025Aug 5, 2025 ↗View →
PRME
PRIME MEDICINE, INC.
PURCHASEGRANT
Stock grant
13,510——13,510Aug 1, 2025Aug 5, 2025 ↗View →
PRME
PRIME MEDICINE, INC.
PURCHASEGRANT
Stock grant
39,062——39,062Aug 1, 2025Aug 5, 2025 ↗View →
PRME
PRIME MEDICINE, INC.
SALE
45,000——0Aug 1, 2025Aug 5, 2025 ↗View →
PRME
PRIME MEDICINE, INC.
PURCHASEGRANT
Stock grant
45,000——45,000Aug 1, 2025Aug 5, 2025 ↗View →
PRME
PRIME MEDICINE, INC.
SALE
13,510——0Aug 1, 2025Aug 5, 2025 ↗View →
PRME
PRIME MEDICINE, INC.
PURCHASEGRANT
Stock grant
9,006——9,006Aug 1, 2025Aug 5, 2025 ↗View →
PRME
PRIME MEDICINE, INC.
SALE
9,006——0Aug 1, 2025Aug 5, 2025 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
74,872——74,872Jun 5, 2025Jun 6, 2025 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,414——72,468Jun 5, 2025Jun 6, 2025 ↗View →
PRME
PRIME MEDICINE, INC.
PURCHASEGRANT
Stock grant
55,000——55,000Jun 4, 2025Jun 4, 2025 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
16,107——16,107Jun 1, 2025Jun 3, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE
12,254——0Jun 1, 2025Jun 3, 2025 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
23,077——23,077Jun 1, 2025Jun 3, 2025 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
12,254——44,009Jun 1, 2025Jun 3, 2025 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
5,000$7.60$38.0K5,000May 27, 2025May 28, 2025 ↗View →
BOOM
DMC GLOBAL INC.
PURCHASEGRANT
Stock grant
17,580——48,653May 14, 2025May 15, 2025 ↗View →
BOOM
DMC GLOBAL INC.
PURCHASEGRANT
Stock grant
5,518——31,073Feb 26, 2025Feb 27, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE
11,336——0Aug 10, 2024Aug 13, 2024 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
11,336——31,755Aug 10, 2024Aug 13, 2024 ↗View →
PRME
PRIME MEDICINE, INC.
PURCHASEGRANT
Stock grant
45,000——45,000Jun 12, 2024Jun 12, 2024 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,467——42,467Jun 6, 2024Jun 7, 2024 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,847——52,054Jun 6, 2024Jun 7, 2024 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
12,254——12,254Jun 1, 2024Jun 4, 2024 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
8,672——8,672Jun 1, 2024Jun 4, 2024 ↗View →
BOOM
DMC GLOBAL INC.
PURCHASEGRANT
Stock grant
9,520——25,555May 15, 2024May 15, 2024 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
8,353——8,353Aug 10, 2023Aug 14, 2023 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
11,336——11,336Aug 10, 2023Aug 14, 2023 ↗View →
PRME
PRIME MEDICINE, INC.
PURCHASEGRANT
Stock grant
39,062——39,062Jun 14, 2023Jun 16, 2023 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,474——30,474Jun 8, 2023Jun 12, 2023 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,584——40,207Jun 8, 2023Jun 12, 2023 ↗View →
BOOM
DMC GLOBAL INC.
PURCHASEGRANT
Stock grant
7,086——16,035May 10, 2023May 10, 2023 ↗View →
PRME
PRIME MEDICINE, INC.
PURCHASEGRANT
Stock grant
9,006——9,006Oct 19, 2022Oct 21, 2022 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
15,556——20,419Jun 10, 2022Jun 14, 2022 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
13,882——13,882Jun 10, 2022Jun 14, 2022 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
45,423——45,423Jun 9, 2022Jun 10, 2022 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,671——31,623Jun 9, 2022Jun 10, 2022 ↗View →
BOOM
DMC GLOBAL INC.
PURCHASEGRANT
Stock grant
5,006——8,949May 11, 2022May 12, 2022 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,750——22,750Jun 30, 2021Jul 1, 2021 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,610——4,610Jun 30, 2021Jul 1, 2021 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,115——18,952Jun 10, 2021Jun 14, 2021 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
36,111——36,111Jun 10, 2021Jun 14, 2021 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
3,081——4,863Jun 2, 2021Jun 4, 2021 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
3,714——3,714Jun 2, 2021Jun 4, 2021 ↗View →
BOOM
DMC GLOBAL INC.
PURCHASEGRANT
Stock grant
1,888——3,943May 12, 2021May 14, 2021 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,837——8,837Dec 1, 2020Dec 2, 2020 ↗View →
FOLD
AMICUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,222——14,222Dec 1, 2020Dec 2, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,000——12,000Sep 28, 2020Sep 29, 2020 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
1,782——1,782Jul 30, 2020Aug 3, 2020 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
2,223——2,223Jul 30, 2020Aug 3, 2020 ↗View →
BOOM
DMC GLOBAL INC.
PURCHASEGRANT
Stock grant
2,055——2,055Jul 24, 2020Jul 28, 2020 ↗View →
Other insiders · FOLD
Loading peer insiders…
About this filer
CIK 0001769668
ROLE
Director
PRIMARY
FOLD
COMPANIES
5
ACTIVE SINCE
Jul 2020
MARKETPEEL · /INSIDER/0001769668DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback